Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Corticosteroid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Heart Valve Diseases
1 trial -
Cow's milk
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Infection
1 trial -
Cyclophosphamide
Ultragenyx UK Limited
Systemic Lupus Erythematosus
1 trial -
DC-TC+GM-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Hepatocellular Carcinoma
1 trial -
Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ERAS
1 trial -
Dentoblis
The First People's Hospital of Lianyungang
Gingivitis; Chronic
2 trials -
Depot Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
Desflurane
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Delirium
1 trial -
Deucravacitinib
The First People's Hospital of Lianyungang
Palmoplantar Pustulosis
1 trial -
Device measurements
COGNITION THERAPEUTICS INC
Healthy
1 trial -
Device measurements during overnight sleep and morning wake
COGNITION THERAPEUTICS INC
Healthy
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Cataract
1 trial -
Dexlansoprazole
Takeda
Laryngo-pharyngeal Reflux
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Benign Neoplasm of Vocal Fold - Glottis
1 trial -
Dexmedetomidine
Shiyou Wei
Lung Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Old Age
1 trial -
Dexmedetomidine
Hospital Authority, Hong Kong
CABG
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Failure
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Anxiety
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiac Surgery
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchoscopy
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Dexmedetomidine
1 trial -
Dexmedetomidine Injection
The First People's Hospital of Lianyungang
Coronary Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources